Cerus Corporation (CERS)
NASDAQ: CERS · Real-Time Price · USD
1.270
-0.010 (-0.78%)
At close: Aug 1, 2025, 4:00 PM
1.260
-0.010 (-0.79%)
After-hours: Aug 1, 2025, 5:06 PM EDT
Cerus Employees
As of December 31, 2024, Cerus had 630 total employees, including 614 full-time and 16 part-time employees. The number of employees decreased by 7 or -1.10% compared to the previous year.
Employees
630
Change (1Y)
-7
Growth (1Y)
-1.10%
Revenue / Employee
$293,879
Profits / Employee
-$30,075
Market Cap
242.77M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 630 | -7 | -1.10% |
| Dec 31, 2023 | 637 | -40 | -5.91% |
| Dec 31, 2022 | 677 | 33 | 5.12% |
| Dec 31, 2021 | 644 | 48 | 8.05% |
| Dec 31, 2020 | 596 | 342 | 134.65% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 94,300 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
CERS News
- 10 days ago - Cerus Corporation to Release Second Quarter 2025 Financial Results on August 5, 2025 - Business Wire
- 12 days ago - Cerus Corporation Announces Additional Department of Defense Award to Advance Care for Major Hemorrhage in Traumatic Injury - Business Wire
- 4 weeks ago - Cerus Corporation Provides INTERCEPT Red Blood Cell CE Mark Application Update - Business Wire
- 7 weeks ago - Cerus Corporation Celebrates World Blood Donor Day 2025 - Business Wire
- 2 months ago - Cerus Corporation to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference 2025 - Business Wire
- 2 months ago - Cerus Corporation Presents Clinical Data for INTERCEPT Blood System at the 35th Regional International Society of Blood Transfusion Congress in Milan - Business Wire
- 2 months ago - Cerus Corporation Announces Multiple In-Country Regulatory Approvals for INT200 – Next-Generation INTERCEPT Illumination Device - Business Wire
- 3 months ago - Cerus Corporation (CERS) Q1 2025 Earnings Call Transcript - Seeking Alpha